CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Routine Foot Care and Nail Debridement Coverage Criteria

Policy governing coverage of routine and non-routine foot care, nail debridement, and foot examinations for Medicare Advantage Plans and Commercial Products administered by Blue Cross & Blue Shield of Rhode Island.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyRoutine Foot Care and Nail Debridement Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionDocument Class A/B/C clinical findings or qualifying local findings in the medical record to support coverage.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

G0127, 11055-11057, 11719-11721Covered CPT/G-codes listed

Class A, B, CClinical finding classes

2019-2023Publication history

Coverage Criteria

Coverage criteria for non-routine foot care and reimbursable routine foot care

Non-routine foot care is covered when ANY of the following systemic or local conditions are met and documented:

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Primary coverage logic

Systemic disease criterion: Systemic disease (metabolic, neurologic, or peripheral vascular) of sufficient severity that performance of such services by a nonprofessional would put the patient at risk (for example, severe circulatory compromise or areas of desensitization in the feet).
Mycotic toenail with functional impact: Clinical evidence of mycosis of the toenail AND, for ambulatory patients: marked limitation of ambulation, pain, or secondary infection resulting from thickening/dystrophy of the infected toenail plate; for non-ambulatory patients: pain or secondary infection resulting from thickening/dystrophy of the infected toenail plate. Covered toenail procedures also include onychogryphosis and onychauxis when documented.
Class findings pathway for routine foot care coverage
- Class A: Any one Class A finding (e.g., non‑traumatic amputation of foot or absent posterior tibial pulse).
- Class B (requirement: 2 of): Advanced trophic changes such as nail thickening, decreased/absent hair growth, pigmentary changes, skin color changes (rubor/redness), thin/shiny skin texture, or absent dorsalis pedis pulse.
- Class C (requirement: 2 of when combined with 1 B): Findings such as claudication, temperature changes (cold feet), edema, paresthesias, and burning.

Documentation requirement: Clinical findings (Class A/B/C) and documentation of systemic disease or qualifying local findings (e.g., mycosis with functional impairment or infection) must be recorded in the medical record to support coverage.

Provider Actions & Billing

Prior Authorization

No prior authorization is required for services addressed by this policy.

Note

Provider Action

Informational: Providers should follow the clinical criteria and documentation guidance in the policy when evaluating and treating foot and toenail conditions.

Documentation Required

Clinical Documentation Requirements

Clinical documentation must support the medical necessity of non-routine foot care. Documented clinical findings (Class A/B/C) or qualifying systemic disease (for example peripheral neuropathy, severe circulatory compromise) are required in the medical record for reimbursement of routine foot care services when claimed as non-routine. For treatment of mycotic nails, document clinical evidence of onychomycosis and, depending on ambulatory status, pain, marked limitation of ambulation, or secondary infection as outlined in the policy. Additional covered toenail procedures require documentation of specific conditions such as onychogryphosis or onychauxis.

Document Class A findings (e.g., non‑traumatic amputation of foot, absent posterior tibial pulse) when applicable
Document qualifying systemic disease (e.g., peripheral neuropathy, severe circulatory embarrassment) when claiming services for systemic-risk patients
For mycotic nails: clinical evidence of mycosis plus ambulatory/non‑ambulatory criteria (pain, limitation of ambulation, or secondary infection) as applicable

Denial Risk

Denial Risk — Routine Indications & Unsupported Diagnoses

Routine foot care and services performed in the absence of localized illness, injury, or symptoms are considered not covered. Claims for routine foot care submitted without the required qualifying diagnoses or documentation risk denial. Submit CPT codes with the appropriate covered diagnosis code(s) per the policy groups; codes submitted for routine indications or unsupported diagnoses may be denied.

Routine foot care (hygienic/preventive maintenance such as cleaning, soaking, use of skin creams) is not covered when no localized illness/injury or qualifying systemic disease is documented
Ensure CPT codes are accompanied by the appropriate diagnosis codes from the policy's covered diagnosis groups to avoid denials
Services for mycotic nails and other covered toenail procedures must meet the policy's documentation and diagnostic requirements or they may be denied

Background

Routine foot care describes hygienic and preventive maintenance of the feet. Examples include activities such as cleaning and soaking, use of skin creams, simple clipping or trimming of nails, cutting or paring of corns and calluses, and other palliative or hygienic treatments performed when there is no localized illness, injury, or symptoms. These services are distinguished from non‑routine procedures (for example, nail debridement for mycotic nails or procedures performed because of systemic disease) that may be covered when qualifying clinical findings are documented.

Definitions

Definition — Routine foot care

Routine foot care — core componentsClipping, trimming, or debridement of nails (including mycotic nails); cutting or removal of corns and calluses; shaving, paring, or removal of keratoma, tyloma, and heloma; other hygienic and preventive maintenance (e.g., cleaning, soaking, use of skin creams); non-definitive palliative treatments such as shaving/paring of plantar warts without cautery.

Performed regardless of providerThese services are considered components of routine foot care regardless of the provider rendering the service (ambulatory or bedfast patients).

Scope — absence of localized diseaseRoutine foot care is defined as services performed in the absence of localized illness, injury, or symptoms involving the foot.

Examples excluded from routine careProcedures requiring thermal or chemical cautery and curettage are not considered routine/palliative simple treatments.

Definition — Nail debridement

DefinitionNail debridement is the significant reduction in thickness and length of the toenail with the aim of allowing the patient to ambulate without pain; it is distinct from simple trimming or buffing.

Not debridement — simple measuresSimple trimming of the ends of toenails by cutting or grinding, reduction in length of normal or elongated toenails (manual or electric burr), and buffing the surface of manually trimmed mycotic toenails are not considered debridement.

Clinical intentPerformed to relieve pain and enable ambulation when nail hypertrophy or dystrophy interferes with function.

Definition — LOPS (Loss of protective sensation)

DefinitionLoss of protective sensation (LOPS) is diabetic sensory neuropathy with loss of protective sensation that requires early intervention to prevent serious complications.

Care frequencyPatients with LOPS may receive two-foot evaluations (examination and treatment) no more often than every six months specifically for diabetic peripheral neuropathy with LOPS.

Diagnosis and coordinationAn MD/DO diagnosis is not strictly necessary for LOPS documentation, but podiatric professionals should coordinate care and promote appropriate diabetic management when LOPS is present.

Clinical significanceLOPS indicates neuropathy severe enough that care by a nonprofessional could put the patient at risk; it may coexist with peripheral neuropathy and onychauxis when ambulation is limited or secondary infection is present.

Revision History

2023-02Provider UpdateLatest

Provider Update published (February 2023).

2022-11Provider Update

Provider Update published (November 2022).

2022-04Provider Update

Provider Update published (April 2022).

2021-04Provider Update

Provider Update published (April 2021).

2021-03Provider Update

Provider Update published (March 2021).

2019-07Provider Update

Provider Update published (July 2019).

11055	Paring or cutting of benign hyperkeratotic lesion (callus); single lesion
11056	Paring or cutting of benign hyperkeratotic lesion (corn or callus); 2 to 4 lesions
11057	Paring or cutting of benign hyperkeratotic lesion (corn or callus); more than 4 lesions
11719	Trimming of nondystrophic nails, any number
11720	Debridement of nail(s) by any method(s); 1 to 5
11721	Debridement of nail(s) by any method(s); 6 or more
G0127	Trimming of dystrophic nails, any number

OpenPayer